Ingenza, a world-leading protein CRDMO – recently welcomed key customers, partners, associates and colleagues to celebrate the official naming and inauguration of its state-of-the-art facility, the inGenius® Building. The relocation follows a strategic review of the company’s long-term development plans,…
Ingenza – a world-leading protein CRDMO – has today announced a strategic relationship with Ab Biotechnology – a MHRA‑licensed GMP facilities provider – to support the development and GMP manufacturing of innovative biotechnology products. With the companies being located and…
A scientist who joined Ingenza as a 16-year-old apprentice has completed a PhD while working full-time at the company – a career path that highlights the long-term impact of work-based learning as part of Scottish Apprenticeship Week. Jack Kay, now…
Ingenza – a world-leading leading engineering biology CRDMO based in Edinburgh, Scotland – has developed GenXpress Bacillus, a powerful orthogonal protein production system. With performance comparable to the best E. coli expression systems, the new technology offers Ingenza customers a highly productive alternative that…
Ingenza Limited, a technology driven contract research, development and manufacturing organisation (CRDMO), recently welcomed Nick Challoner as its new Chief Executive Officer. Nick is a seasoned leader with more than three decades of experience in innovation, strategy and international business…
Ingenza Limited, a technology driven contract research, development and manufacturing organisation (CRDMO), has announced the appointment of Nick Challoner as its new Chief Executive Officer, effective the 1st of October, 2025. Nick brings over 30 years of experience in business…
Ingenza is delighted to announce its relocation to The Moubray Building at Edinburgh Technopole, part of the Pioneer Group. The new site is still within the Midlothian Science Zone – a world-leading centre of research excellence in life sciences –…
Ingenza has partnered with Oxford-based biotech company HydRegen to develop a more sustainable and cost-effective method for manufacturing amine-based chemicals, eliminating the need for heavy metal catalysts. The company turned to Ingenza to help improve the expression levels of a new candidate biocatalyst,…
Ingenza – a world-leading contract research, development and manufacturing organisation (CRDMO) and technology accelerator – is delighted to announce its plans to relocate to the Moubray Building at Edinburgh Technopole, part of Pioneer Group. Following a detailed strategic review, the company has embarked on…
Enzyme evolution can be used to take a wild-type enzyme that is in some way unsuitable for a bioprocess of interest and create a strain with enhanced capabilities. This iterative process is based on the design-build-test-learn (DBTL) cycle,1 and can be used…